Frequency Therapeutics Stock Buy Hold or Sell Recommendation
| KRRO Stock | 52.31 1.69 3.34% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Frequency Therapeutics is 'Hold'. The recommendation algorithm takes into account all of Frequency Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Frequency Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide. In addition, we conduct extensive research on individual companies such as Frequency and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Frequency |
Execute Frequency Therapeutics Buy or Sell Advice
The Frequency recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Frequency Therapeutics. Macroaxis does not own or have any residual interests in Frequency Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Frequency Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Frequency Therapeutics Trading Alerts and Improvement Suggestions
| Frequency Therapeutics is way too risky over 90 days horizon | |
| Frequency Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (81.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Frequency Therapeutics generates negative cash flow from operations | |
| Frequency Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 91.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Korro Bio Given Buy Rating at HC Wainwright |
Frequency Therapeutics Returns Distribution Density
The distribution of Frequency Therapeutics' historical returns is an attempt to chart the uncertainty of Frequency Therapeutics' future price movements. The chart of the probability distribution of Frequency Therapeutics daily returns describes the distribution of returns around its average expected value. We use Frequency Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Frequency Therapeutics returns is essential to provide solid investment advice for Frequency Therapeutics.
| Mean Return | 0.79 | Value At Risk | -8.79 | Potential Upside | 7.70 | Standard Deviation | 12.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Frequency Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Frequency Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 158.0M | 20.2M | 44.4M | (42.6M) | 131.6M | 138.2M | |
| Free Cash Flow | 33.2M | (51.9M) | (36.5M) | (58.9M) | (75.1M) | (71.4M) | |
| Change In Working Capital | 48.6M | (30.2M) | 904K | (633K) | 4.3M | 2.7M | |
| Begin Period Cash Flow | 42.2M | 200.2M | 39.7M | 84.0M | 41.5M | 67.9M | |
| Other Cashflows From Financing Activities | (18.3M) | 10.4M | 115.9M | 18K | 70.5M | 74.0M | |
| Depreciation | 813K | 1.6M | 1.6M | 2.5M | 3.6M | 3.8M | |
| Other Non Cash Items | 5.8M | 8.9M | (13.5M) | 1.5M | 3.6M | 3.8M | |
| Capital Expenditures | 1.1M | 6.7M | 4.4M | 5.2M | 7.8M | 4.3M | |
| Total Cash From Operating Activities | 34.2M | (45.2M) | (32.1M) | (53.6M) | (67.3M) | (63.9M) | |
| Net Income | (18.7M) | (26.5M) | (22.0M) | (58.0M) | (81.2M) | (77.1M) | |
| Total Cash From Financing Activities | 142.0M | 56.7M | 115.9M | 18K | 187.8M | 197.1M | |
| End Period Cash Flow | 200.2M | 220.3M | 84.0M | 41.5M | 173.1M | 122.5M |
Frequency Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Frequency Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Frequency Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Frequency stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 3.87 | |
σ | Overall volatility | 12.72 | |
Ir | Information ratio | 0.05 |
Frequency Therapeutics Volatility Alert
Frequency Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Frequency Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Frequency Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Frequency Therapeutics Fundamentals Vs Peers
Comparing Frequency Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Frequency Therapeutics' direct or indirect competition across all of the common fundamentals between Frequency Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Frequency Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Frequency Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Frequency Therapeutics to competition |
| Fundamentals | Frequency Therapeutics | Peer Average |
| Return On Equity | -0.75 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Current Valuation | 394.84 M | 16.62 B |
| Shares Outstanding | 9.37 M | 571.82 M |
| Shares Owned By Insiders | 6.44 % | 10.09 % |
| Shares Owned By Institutions | 91.37 % | 39.21 % |
| Number Of Shares Shorted | 261.96 K | 4.71 M |
| Price To Book | 2.73 X | 9.51 X |
| EBITDA | (80.9 M) | 3.9 B |
| Net Income | (81.17 M) | 570.98 M |
| Total Debt | 33.21 M | 5.32 B |
| Book Value Per Share | 19.28 X | 1.93 K |
| Cash Flow From Operations | (67.28 M) | 971.22 M |
| Short Ratio | 1.57 X | 4.00 X |
| Earnings Per Share | (9.42) X | 3.12 X |
| Target Price | 137.76 | |
| Number Of Employees | 101 | 18.84 K |
| Market Capitalization | 490.05 M | 19.03 B |
| Total Asset | 221.66 M | 29.47 B |
| Retained Earnings | (183 M) | 9.33 B |
| Working Capital | 153.25 M | 1.48 B |
| Net Asset | 221.66 M |
Note: Disposition of 800 shares by Agarwal Vineet of Frequency Therapeutics at 70.0 subject to Rule 16b-3 [view details]
Frequency Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Frequency . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Frequency Therapeutics Buy or Sell Advice
When is the right time to buy or sell Frequency Therapeutics? Buying financial instruments such as Frequency Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Frequency Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Climate Change Thematic Idea Now
Climate Change
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Frequency Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.42) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.